Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research.Psychedelic medicine (New Rochelle, N.Y.) · 2026-09-01Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe AnxietyDrugs and Drug Candidates · 2026-08-12Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participantsNeuropsychopharmacology · 2026-07-01Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges.Journal of psychiatric research · 2026-06-23Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy ParticipantsBiological Psychiatry · 2026-05-01Optimization of Psilocybin Extraction from Psilocybe cubensis Mushrooms and Characterization of the Fungal ExtractJournal of the Brazilian Chemical Society · 2026-01-01A novel psychedelic 5-HT receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer.Journal of psychopharmacology (Oxford, England) · 2026-01-01An exploration of the relationships between the effects of psilocybin on behavior, 5-HT receptor occupancy, and neuroplastic effects in mice.Journal of psychopharmacology (Oxford, England) · 2026-01-01Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin CompoundsACS Omega · 2025-09-30Exploring the Frontiers of Psychedelics: A New Chromatographic Method for Detection and Quantification of Psilocybin and Psilocin in Psilocybe cubensis MushroomsACS Omega · 2025-07-22Chemical Composition and Biological Activities of Mushrooms: Gaps and Perspectives.Pharmaceuticals (Basel, Switzerland) · 2025-07-01Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.Clinical pharmacology and therapeutics · 2025-06-01Extraction Yields of Psilocybin and Psilocin: A Short Review of Current Methods and Their ImplicationsPharmaceuticals · 2025-03-07A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.Cureus · 2025-03-01An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).Pilot and feasibility studies · 2023-10-05Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-10-01Alternative Options for Complex, Recurrent Pain States Using Cannabinoids, Psilocybin, and Ketamine: A Narrative Review of Clinical Evidence.Neurology international · 2022-05-18The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant ActionInstitutional Repositories DataBase (IRDB) · 2020-12-03The Effects of Daytime Psilocybin Administration on Sleep: Implications for Antidepressant Action.Frontiers in pharmacology · 2020-01-01Psychedelic Drugs in Biomedicine.Trends in pharmacological sciences · 2017-11-01DNA-based taxonomic identification of basidiospores in hallucinogenic mushrooms cultivated in “grow-kits” seized by the police: LC-UV quali-quantitative determination of psilocybin and psilocinJournal of Pharmaceutical and Biomedical Analysis · 2016-06-01Recreational drug discovery: natural products as lead structures for the synthesis of smart drugs.Natural product reports · 2014-07-01A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.The American journal of drug and alcohol abuse · 2013-09-01Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis.Psychopharmacology · 2008-07-01